Skin Diseases, Infectious Completed Phase 4 Trials for Tigecycline (DB00560)

Also known as: Infectious Skin Disease / Infectious Skin Diseases / Skin Disease, Infectious

IndicationStatusPhase
DBCOND0032714 (Skin Diseases, Infectious)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00488761Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSITreatment